Continuum Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Continuum Advisory's VRTX Position: Q1 2026 in Review

Continuum Advisory reduced its Vertex Pharmaceuticals (VRTX) stake by 58% in Q1 2026, selling an estimated $442K and leaving 685 shares worth $306K. The position accounts for 0.03% of the portfolio, ranked #362.

Continuum Advisory first reported a position in VRTX in Q3 2022 and has held it in 15 quarters since. The position peaked at $807K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

• Continuum Advisory held 685 shares of Vertex Pharmaceuticals worth $306K as of Q1 2026.
• Continuum Advisory sold 947 Vertex Pharmaceuticals shares in Q1 2026, an estimated $442K.
• Vertex Pharmaceuticals made up 0.03% of Continuum Advisory's portfolio in Q1 2026, its #362 holding.
• Continuum Advisory first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
• Continuum Advisory's Vertex Pharmaceuticals position peaked at $807K in Q1 2025.
• 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.